MENU
+Compare
RENB
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$0.29
Change
-$0.06 (-17.14%)
Capitalization
50.38M

RENB Renovaro Forecast, Technical & Fundamental Analysis

Renovaro Inc is a biopharmaceutical company... Show more

RENB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RENB with price predictions
Jun 27, 2025

RENB in upward trend: price may ascend as a result of having broken its lower Bollinger Band on June 27, 2025

RENB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 41 cases where RENB's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The 10-day moving average for RENB crossed bullishly above the 50-day moving average on June 17, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where RENB advanced for three days, in of 251 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RENB as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for RENB turned negative on June 27, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

RENB moved below its 50-day moving average on June 27, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RENB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. RENB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.570) is normal, around the industry mean (16.366). P/E Ratio (0.000) is within average values for comparable stocks, (58.189). RENB's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.247).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RENB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
RENB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a financial conglomerate

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Financial Conglomerates
Address
2080 Century Park East
Phone
+1 305 918-1980
Employees
12
Web
https://www.enochianbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SDCH0.060.01
+19.82%
SideChannel Inc.
ACCS12.540.79
+6.72%
ACCESS Newswire Inc
FRACF1.41N/A
N/A
Foraco International, Marseille
NPEGF23.97N/A
N/A
Nippon Electric Glass Co., Ltd.
IMDZF127.82N/A
N/A
IMCD NV

RENB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RENB has been loosely correlated with DTIL. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RENB jumps, then DTIL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RENB
1D Price
Change %
RENB100%
-16.16%
DTIL - RENB
36%
Loosely correlated
+3.86%
TNGX - RENB
30%
Poorly correlated
+1.83%
XBIT - RENB
27%
Poorly correlated
-2.44%
QRON - RENB
25%
Poorly correlated
N/A
BRCTF - RENB
25%
Poorly correlated
N/A
More